[144] Insmed, Inc. SEC Filing
Insmed, Inc. (INSM) filed a Form 144 proposing the sale of 6,865 common shares under Rule 144, with an approximate aggregate market value of $881,244, to be sold through Merrill Lynch on NASDAQ on 08/18/2025. The filing states those shares were acquired on 08/18/2025 through stock plan activity and lists prior sales by the same account (William Lewis and William Lewis TTEE) totaling multiple transactions from 05/20/2025 through 08/04/2025, including a large sale of 129,805 shares on 06/16/2025 generating $13,027,678. The notice includes the standard Rule 144 attestation that the seller is not aware of undisclosed material adverse information.
Insmed, Inc. (INSM) ha presentato un Modulo 144 proponendo la vendita di 6.865 azioni ordinarie ai sensi della Rule 144, per un valore di mercato aggregato approssimativo di $881.244, tramite Merrill Lynch su NASDAQ in data 18/08/2025. Il deposito indica che tali azioni sono state acquisite il 18/08/2025 tramite attivit脿 del piano azionario e riporta vendite precedenti dallo stesso conto (William Lewis e William Lewis TTEE) che comprendono pi霉 operazioni dal 20/05/2025 al 04/08/2025, inclusa una consistente cessione di 129.805 azioni il 16/06/2025 per $13.027.678. L鈥檃vviso contiene la consueta attestazione prevista dalla Rule 144, secondo la quale il venditore non 猫 a conoscenza di informazioni materiali sfavorevoli non divulgate.
Insmed, Inc. (INSM) present贸 un Formulario 144 proponiendo la venta de 6.865 acciones comunes bajo la Rule 144, por un valor de mercado agregado aproximado de $881.244, a trav茅s de Merrill Lynch en NASDAQ el 18/08/2025. La presentaci贸n indica que esas acciones se adquirieron el 18/08/2025 mediante actividad del plan de acciones y enumera ventas previas de la misma cuenta (William Lewis y William Lewis TTEE) que abarcan m煤ltiples transacciones desde el 20/05/2025 hasta el 04/08/2025, incluida una gran venta de 129.805 acciones el 16/06/2025 que gener贸 $13.027.678. El aviso incluye la declaraci贸n est谩ndar de la Rule 144 de que el vendedor no tiene conocimiento de informaci贸n material adversa no divulgada.
Insmed, Inc. (INSM)鞚� Rule 144鞐� 霐半澕 6,865欤� 氤错喌欤� 毵り皝鞚� 鞝滌晥頃橂姅 Form 144毳� 鞝滌稖頄堨溂氅�, 齑� 鞁滌灔臧�旃橂姅 鞎� $881,244搿� 2025雲� 8鞗� 18鞚� NASDAQ鞐愳劀 Merrill Lynch毳� 韱淀暣 毵り皝霅� 鞓堨爼鞛呺媹雼�. 鞝滌稖靹滌棎電� 頃措嫻 欤检嫕鞚� 2025雲� 8鞗� 18鞚� 鞀ろ啞 頂岆灉 頇滊彊鞚� 韱淀暣 旆摑霅橃棃鞙茧┌, 霃欖澕 瓿勳爼(William Lewis 氚� William Lewis TTEE)鞐� 鞚橅暅 2025雲� 5鞗� 20鞚茧秬韯� 8鞗� 4鞚缄箤歆�鞚� 雼れ垬 瓯半灅毳� 韽暔頃� 鞚挫爠 毵り皝 雮挫棴鞚� 旮办灛霅橃柎 鞛堦碃, 攴胳 2025雲� 6鞗� 16鞚检棎 129,805欤茧ゼ 雽�攴滊搿� 毵り皝頃橃棳 $13,027,678毳� 氚滌儩鞁滍偍 瓯半灅臧� 韽暔霅橃柎 鞛堧嫟瓿� 霅橃柎 鞛堨姷雼堧嫟. 韱奠氍胳棎電� 韺愲Г鞛愱皜 氙戈车臧滊悳 欷戩殧 攵堧Μ頃� 鞝曤炒毳� 鞎岅碃 鞛堨 鞎婋嫟電� Rule 144鞚� 響滌 頇曥澑靹滊弰 韽暔霅橃柎 鞛堨姷雼堧嫟.
Insmed, Inc. (INSM) a d茅pos茅 un Formulaire 144 proposant la vente de 6 865 actions ordinaires en vertu de la Rule 144, pour une valeur de march茅 agr茅g茅e d鈥檈nviron 881 244 $, via Merrill Lynch sur le NASDAQ le 18/08/2025. Le d茅p么t indique que ces actions ont 茅t茅 acquises le 18/08/2025 par activit茅 du plan d鈥檃ctions et mentionne des ventes ant茅rieures effectu茅es par le m锚me compte (William Lewis et William Lewis TTEE) totalisant plusieurs op茅rations du 20/05/2025 au 04/08/2025, y compris une vente importante de 129 805 actions le 16/06/2025 g茅n茅rant 13 027 678 $. L鈥檃vis contient l鈥檃ttestation standard pr茅vue par la Rule 144 selon laquelle le vendeur n鈥檃 pas connaissance d鈥檌nformations d茅favorables mat茅rielles non divulg茅es.
Insmed, Inc. (INSM) hat ein Formular 144 eingereicht, in dem der Verkauf von 6.865 Stammaktien gem盲脽 Rule 144 vorgeschlagen wird, mit einem ungef盲hren aggregierten Marktwert von $881.244, der 眉ber Merrill Lynch an der NASDAQ am 18.08.2025 ver盲u脽ert werden soll. Die Einreichung besagt, dass diese Aktien am 18.08.2025 durch Aktivit盲ten des Aktienplans erworben wurden und listet fr眉here Verk盲ufe desselben Kontos (William Lewis und William Lewis TTEE) mit mehreren Transaktionen vom 20.05.2025 bis zum 04.08.2025 auf, einschlie脽lich eines gro脽en Verkaufs von 129.805 Aktien am 16.06.2025, der $13.027.678 einbrachte. Die Mitteilung enth盲lt die 眉bliche Rule-144-Erkl盲rung, dass der Verk盲ufer nicht 眉ber nicht offengelegte wesentliche nachteilige Informationen informiert ist.
- None.
- None.
Insights
TL;DR: Routine Rule 144 sale tied to stock-plan issuance; recent aggregated insider sales are notable but not conclusive.
The filing documents a planned sale of 6,865 shares acquired via a stock plan on the same date as the proposed sale, filed to comply with Rule 144. The historical sales log shows frequent dispositions by the same beneficial holder or trustee across May鈥揂ugust 2025, including a material block of 129,805 shares on 06/16/2025 that produced $13,027,678. These patterns can affect supply dynamics but the filing contains no financial results or forward-looking statements; impact appears neutral absent additional company context.
TL;DR: Multiple recent insider/trustee sales, including a large block, raise governance and signaling concerns.
The record of repeated sales by William Lewis and William Lewis TTEE within a short window, culminating in a large 129,805-share sale, could be viewed negatively by investors as insider liquidity events. The Form 144 shows the new 6,865-share sale stems from stock plan activity, but frequent dispositions by related parties warrant scrutiny of insider motivations and lock-up or plan schedules. The filing does not provide explanations or company disclosures to mitigate potential investor concerns.
Insmed, Inc. (INSM) ha presentato un Modulo 144 proponendo la vendita di 6.865 azioni ordinarie ai sensi della Rule 144, per un valore di mercato aggregato approssimativo di $881.244, tramite Merrill Lynch su NASDAQ in data 18/08/2025. Il deposito indica che tali azioni sono state acquisite il 18/08/2025 tramite attivit脿 del piano azionario e riporta vendite precedenti dallo stesso conto (William Lewis e William Lewis TTEE) che comprendono pi霉 operazioni dal 20/05/2025 al 04/08/2025, inclusa una consistente cessione di 129.805 azioni il 16/06/2025 per $13.027.678. L鈥檃vviso contiene la consueta attestazione prevista dalla Rule 144, secondo la quale il venditore non 猫 a conoscenza di informazioni materiali sfavorevoli non divulgate.
Insmed, Inc. (INSM) present贸 un Formulario 144 proponiendo la venta de 6.865 acciones comunes bajo la Rule 144, por un valor de mercado agregado aproximado de $881.244, a trav茅s de Merrill Lynch en NASDAQ el 18/08/2025. La presentaci贸n indica que esas acciones se adquirieron el 18/08/2025 mediante actividad del plan de acciones y enumera ventas previas de la misma cuenta (William Lewis y William Lewis TTEE) que abarcan m煤ltiples transacciones desde el 20/05/2025 hasta el 04/08/2025, incluida una gran venta de 129.805 acciones el 16/06/2025 que gener贸 $13.027.678. El aviso incluye la declaraci贸n est谩ndar de la Rule 144 de que el vendedor no tiene conocimiento de informaci贸n material adversa no divulgada.
Insmed, Inc. (INSM)鞚� Rule 144鞐� 霐半澕 6,865欤� 氤错喌欤� 毵り皝鞚� 鞝滌晥頃橂姅 Form 144毳� 鞝滌稖頄堨溂氅�, 齑� 鞁滌灔臧�旃橂姅 鞎� $881,244搿� 2025雲� 8鞗� 18鞚� NASDAQ鞐愳劀 Merrill Lynch毳� 韱淀暣 毵り皝霅� 鞓堨爼鞛呺媹雼�. 鞝滌稖靹滌棎電� 頃措嫻 欤检嫕鞚� 2025雲� 8鞗� 18鞚� 鞀ろ啞 頂岆灉 頇滊彊鞚� 韱淀暣 旆摑霅橃棃鞙茧┌, 霃欖澕 瓿勳爼(William Lewis 氚� William Lewis TTEE)鞐� 鞚橅暅 2025雲� 5鞗� 20鞚茧秬韯� 8鞗� 4鞚缄箤歆�鞚� 雼れ垬 瓯半灅毳� 韽暔頃� 鞚挫爠 毵り皝 雮挫棴鞚� 旮办灛霅橃柎 鞛堦碃, 攴胳 2025雲� 6鞗� 16鞚检棎 129,805欤茧ゼ 雽�攴滊搿� 毵り皝頃橃棳 $13,027,678毳� 氚滌儩鞁滍偍 瓯半灅臧� 韽暔霅橃柎 鞛堧嫟瓿� 霅橃柎 鞛堨姷雼堧嫟. 韱奠氍胳棎電� 韺愲Г鞛愱皜 氙戈车臧滊悳 欷戩殧 攵堧Μ頃� 鞝曤炒毳� 鞎岅碃 鞛堨 鞎婋嫟電� Rule 144鞚� 響滌 頇曥澑靹滊弰 韽暔霅橃柎 鞛堨姷雼堧嫟.
Insmed, Inc. (INSM) a d茅pos茅 un Formulaire 144 proposant la vente de 6 865 actions ordinaires en vertu de la Rule 144, pour une valeur de march茅 agr茅g茅e d鈥檈nviron 881 244 $, via Merrill Lynch sur le NASDAQ le 18/08/2025. Le d茅p么t indique que ces actions ont 茅t茅 acquises le 18/08/2025 par activit茅 du plan d鈥檃ctions et mentionne des ventes ant茅rieures effectu茅es par le m锚me compte (William Lewis et William Lewis TTEE) totalisant plusieurs op茅rations du 20/05/2025 au 04/08/2025, y compris une vente importante de 129 805 actions le 16/06/2025 g茅n茅rant 13 027 678 $. L鈥檃vis contient l鈥檃ttestation standard pr茅vue par la Rule 144 selon laquelle le vendeur n鈥檃 pas connaissance d鈥檌nformations d茅favorables mat茅rielles non divulg茅es.
Insmed, Inc. (INSM) hat ein Formular 144 eingereicht, in dem der Verkauf von 6.865 Stammaktien gem盲脽 Rule 144 vorgeschlagen wird, mit einem ungef盲hren aggregierten Marktwert von $881.244, der 眉ber Merrill Lynch an der NASDAQ am 18.08.2025 ver盲u脽ert werden soll. Die Einreichung besagt, dass diese Aktien am 18.08.2025 durch Aktivit盲ten des Aktienplans erworben wurden und listet fr眉here Verk盲ufe desselben Kontos (William Lewis und William Lewis TTEE) mit mehreren Transaktionen vom 20.05.2025 bis zum 04.08.2025 auf, einschlie脽lich eines gro脽en Verkaufs von 129.805 Aktien am 16.06.2025, der $13.027.678 einbrachte. Die Mitteilung enth盲lt die 眉bliche Rule-144-Erkl盲rung, dass der Verk盲ufer nicht 眉ber nicht offengelegte wesentliche nachteilige Informationen informiert ist.
